Principles of Reporting. The results of operations of the will be presented in the following format (on a per Product basis), with the categories as defined in Section A.1 above: [*] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended. It is the intention of the Parties that the interpretation of these definitions will be in accordance with GAAP.
Appears in 3 contracts
Sources: License and Collaboration Agreement (Portola Pharmaceuticals Inc), License and Collaboration Agreement (Portola Pharmaceuticals Inc), License and Collaboration Agreement (Portola Pharmaceuticals Inc)